Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H15NO2.ClH |
| Molecular Weight | 217.693 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=C(OC)C=C(CCN)C=C1
InChI
InChIKey=WIOOTMZLCZPTDW-UHFFFAOYSA-N
InChI=1S/C10H15NO2.ClH/c1-12-9-4-3-8(5-6-11)7-10(9)13-2;/h3-4,7H,5-6,11H2,1-2H3;1H
| Molecular Formula | C10H15NO2 |
| Molecular Weight | 181.2316 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Homoveratrylamine (3,4-dimethoxyphenethylamine, DMPEA) is an analog of the major neurotransmitter dopamine where 3- and 4- position hydroxyl groups are replaced with methoxy groups. DMPEA is a metabolite of dopamine and is reported to be produced at elevated levels in patients with schizophrenia and Parkinson's disease. DMPEA inhibited monoamine oxidase and demonstrated no peripheral and central antidopaminergic activity in vivo.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095205 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14459693 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Selective electrochemical discrimination between dopamine and phenethylamine-derived psychotropic drugs using electrodes modified with an acyclic receptor containing two terminal 3-alkoxy-5-nitroindazole rings. | 2010-06 |
|
| (E)-N-(3,4-Dimethoxy-pheneth-yl)-3-methoxy-but-2-enamide. | 2010-01-23 |
|
| An overview of Indian research in schizophrenia. | 2010-01 |
|
| Enhancement of 5-aminopenta-2,4-dienals electrophilicity via activation by O,N-bistrifluoroacetylation. application to an N-acyl Pictet-Spengler reaction. | 2009-12-18 |
|
| Self-assembly of 3,5-bis(ethoxycarbonyl)pyrazolate anions and ammonium cations of beta-phenylethylamine or homoveratrylamine into hetero-double-stranded helical structures. | 2009-08-21 |
|
| 2-(4-Chloro-phen-yl)-5-(3,4-dimethoxy-pheneth-yl)-6,7-dihydro-pyrazolo[1,5-a]pyrazin-4(5H)-one. | 2009-06-06 |
|
| Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases). | 2009-03 |
|
| 4-[2-(3,4-Dimethoxy-phenethyl-amino)prop-oxy]-2-methoxy-benzamide. | 2008-05-24 |
|
| Evaluation of dimethoxydop-NU as a novel anti-tumor agent. | 2007-12 |
|
| The structure of ammonium pyrazolates in the solid state. | 2006-12 |
|
| [Syntheses and ring-closures of difunctional tetrahydroisoquinolines]. | 2006 |
|
| Contribution of aldehyde oxidizing enzymes on the metabolism of 3,4-dimethoxy-2-phenylethylamine to 3,4-dimethoxyphenylacetic acid by guinea pig liver slices. | 2006 |
|
| Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases. | 2004-11 |
|
| Kinetics study of amine cleavage reactions of various resin-bound thiophenol esters from marshall linker. | 2002-07-09 |
|
| Fine structural specificity differences of trimethoprim allergenic determinants. | 1996-10 |
|
| 3,4-dimethoxyphenethylamine (DMPEA) and schizophrenia. | 1979-02 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27614
In vivo experiments with DMPEA were performed on mice. Compound was administered intraperitoneally at doses 25-200 mg/kg.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14459693
Brain mitochondria, containing monoamine oxidase, were prepared from Wistar female rats. Monoamine oxidase activity was determined in the presence and absence of the DMPEA by manometric technique. The main compartment of Warburg flasks contained 0.8 ml of a 0.1 M buffered solution of the homoveratrylamine, 1 ml of mitochondrial suspension (representing 500 mg wet weight of original brain tissue), and sufficient 0.01 M phosphate buffer (pH 7.4) to make a total volume of 2.7 ml. All aliquots for a given run were taken from the same mitochondrial preparation. The side arm of each flask contained 0.3 ml of 0.1 M tyramine or tryptamine hydrochloride. After the flasks were allowed to equilibrate for 15 min at 37°, the manometer valves were closed and the side arm contents of each were tipped in. Manometers were set at 150 mm, and readings were taken at 15-min intervals for 90 min. Values for the 90-min reaction period were obtained for each flask and were multiplied by the respective flask constants after adjusting for changes in the thermobarometer. The total microliters of oxygen uptake for each flask was thus obtained.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:15:43 GMT 2025
by
admin
on
Mon Mar 31 21:15:43 GMT 2025
|
| Record UNII |
TTV20379WY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
14141
Created by
admin on Mon Mar 31 21:15:43 GMT 2025 , Edited by admin on Mon Mar 31 21:15:43 GMT 2025
|
PRIMARY | |||
|
141621
Created by
admin on Mon Mar 31 21:15:43 GMT 2025 , Edited by admin on Mon Mar 31 21:15:43 GMT 2025
|
PRIMARY | |||
|
71555
Created by
admin on Mon Mar 31 21:15:43 GMT 2025 , Edited by admin on Mon Mar 31 21:15:43 GMT 2025
|
PRIMARY | |||
|
635-85-8
Created by
admin on Mon Mar 31 21:15:43 GMT 2025 , Edited by admin on Mon Mar 31 21:15:43 GMT 2025
|
PRIMARY | |||
|
TTV20379WY
Created by
admin on Mon Mar 31 21:15:43 GMT 2025 , Edited by admin on Mon Mar 31 21:15:43 GMT 2025
|
PRIMARY | |||
|
DTXSID00212904
Created by
admin on Mon Mar 31 21:15:43 GMT 2025 , Edited by admin on Mon Mar 31 21:15:43 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|